Haemonetics (NYSE:HAE) shares dipped slightly on second-quarter results that topped the consensus forecast. The Boston-based blood management technology developer posted profits of $48.1 million, or 94¢ per share, on sales of $209.5 million for the three months ended Sept. 26, 2020, for a 28.3% bottom-line gain on a sales decline of -17.1%. Adjusted to exclude one-time […]
Haemonetics
FDA clears Haemonetics’ plasma collection system
Haemonetics (NYSE:HAE) announced that it received FDA 510(k) clearance for its NexSys PCS system with Persona technology. Boston-based Haemonetics’ new, proprietary Persona technology customizes plasma collection based on an individual donor’s body composition, according to a news release. NexSys PCS (plasma collection system) with Persona is intended for use as an automated cell separator system and […]
MedTech 100 roundup: Industry remains on the rise
The medtech industry continues to climb back up in the markets, following a landmark week with another move up toward its pre-COVID-19-pandemic highs. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.29 points at the end of last week (July 24). That total represents just a […]
Haemonetics to sell Inlog Holdings France subsidiary
Haemonetics (NYSE:HAE) announced today that it entered into an agreement to sell its wholly-owned subsidiary Inlog Holdings France SAS to Abénex. France-based Abénex, a fully independent private equity firm, will take on the Haemonetics subsidiary which develops and sells blood bank and hospital software solutions, predominantly in France and in other countries outside the U.S. Boston-based […]
Haemonetics’ blood-collection devices could leave particles in donors, report says
A consortium of news outlets is questioning the safety of Haemonetics (NYSE:HAE) blood-collection devices, claiming that particles have been detected in donors whose plasma was extracted by the machines. According to a report in the Miami Herald, whistleblower documents indicate that more than 150 Haemonetics customer reports have been made regarding the presence of particles by plasma […]
Haemonetics to sell filter factory to GVS
Haemonetics (NYSE:HAE) said today that it has agreed to sell its Fajardo, Puerto Rico, manufacturing operations to filter manufacturer GVS. Boston-based Haemonetics will retain all intellectual property rights to its proprietary blood filters currently manufactured at its Fajardo facility, while GVS (Bologna, Italy) will obtain certain operating assets, including manufacturing equipment and inventory and a sublease […]
MedTech 100 roundup: Stocks peak to end May
Medtech stocks closed May at their highest point since before the COVID-19 pandemic rocked the markets. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 87.17 points at the end of last week (May 29). That total represents a 2.3% gain from the 85.22-point total at the […]
Haemonetics sells off blood donor software
Haemonetics (NYSE:HAE) announced today that it plans to sell certain blood donor management software assets to the GPI Group. GPI, a provider of IT solutions for healthcare and social services, is purchasing the assets from within Haemonetics’ blood center business unit, according to a news release. Under the agreement, Boston-based Haemonetics and its subsidiary Global Med […]
MedTech 100 roundup: Stocks open strong in May
Medtech stocks took a dip as April came to a close, but opened May with a strong week as the COVID-19 pandemic continues to affect the economy. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 83.98 points at the end of last week (May 8). That […]
Haemonetics slides on missed 4Q projections
Haemonetics (NYSE:HAE) shares slid today on fourth-quarter results that came up short compared to the consensus forecast. The Boston-based company posted profits of $17.6 million, or 34¢ per share, on sales of $238.5 million for the three months ended March 28, 2020, for a -15.4% bottom-line slide on a sales decline of -4.3%. Adjusted to exclude […]
Haemonetics acquires Enicor
Haemonetics (NYSE:HAE) announced that it acquired next-generation whole blood coagulation testing system developer Enicor GmbH for an undisclosed amount. Munich, Germany-based Enicor develops the ClotPro system designed for viscoelastic diagnostics touted to offer more assays than any other hemostasis analyzer on the market. Haemonetics said in a news release that ClotPro is set to be coupled […]